Parallel Advisors’s Aclaris Therapeutics ACRS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-500
| Closed | -$5.19K | – | 3342 |
|
|
2023
Q2 | $5.19K | Hold |
500
| – | – | ﹤0.01% | 2416 |
|
|
2023
Q1 | $4.05K | Sell |
500
-100
| -17% | -$809 | ﹤0.01% | 2483 |
|
|
2022
Q4 | $9.45K | Hold |
600
| – | – | ﹤0.01% | 2050 |
|
|
2022
Q3 | $9K | Sell |
600
-24
| -4% | -$360 | ﹤0.01% | 1997 |
|
|
2022
Q2 | $9K | Buy |
624
+24
| +4% | +$346 | ﹤0.01% | 1991 |
|
|
2022
Q1 | $11K | Buy |
+600
| New | +$11K | ﹤0.01% | 1935 |
|
|
2021
Q3 | – | Sell |
-100
| Closed | -$2K | – | 3023 |
|
|
2021
Q2 | $2K | Sell |
100
-1,100
| -92% | -$22K | ﹤0.01% | 2493 |
|
|
2021
Q1 | $30K | Sell |
1,200
-400
| -25% | -$10K | ﹤0.01% | 1391 |
|
|
2020
Q4 | $10K | Sell |
1,600
-2,250
| -58% | -$14.1K | ﹤0.01% | 1751 |
|
|
2020
Q3 | $10K | Hold |
3,850
| – | – | ﹤0.01% | 1700 |
|
|
2020
Q2 | $6K | Hold |
3,850
| – | – | ﹤0.01% | 1876 |
|
|
2020
Q1 | $4K | Hold |
3,850
| – | – | ﹤0.01% | 1931 |
|
|
2019
Q4 | $7K | Sell |
3,850
-400
| -9% | -$727 | ﹤0.01% | 1833 |
|
|
2019
Q3 | $5K | Hold |
4,250
| – | – | ﹤0.01% | 1879 |
|
|
2019
Q2 | $9K | Buy |
4,250
+1,250
| +42% | +$2.65K | ﹤0.01% | 1607 |
|
|
2019
Q1 | $18K | Sell |
3,000
-1,250
| -29% | -$7.5K | ﹤0.01% | 1250 |
|
|
2018
Q4 | $31K | Buy |
4,250
+1,340
| +46% | +$9.77K | ﹤0.01% | 911 |
|
|
2018
Q3 | $42K | Buy |
+2,910
| New | +$42K | 0.01% | 871 |
|